Oncotrace RGCC

Oncotrace RGCC is designed as a preliminary screening tool to identify the presence of circulating tumor cells (CTCs) and can be beneficial for individuals looking to take the first step in assessing their cancer risk.

​

During the test, a sample of blood is analyzed to identify the presence and concentration of circulating tumor cells (CTCs) and their concentration. This test provides information about the presence of CTCs, their concentration and their specific type (immunophenotype).

​

The results of the test enable clinicians to identify the origin of a tumor where this is unknown and to provide information on the development of cancer and the prognosis.